EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
[…](2021) XXX  draft  
ANNEX  
 
ANNEX  
to the  
Commission Delegated Regulation  
amending, for the purposes of its adaptation for technical and scientific progress to 
Regulation (EC) No 1272/2008 of the European Parliament and of the Council on 
classification, labelling and packaging of substances and mixtures    
EN 1  EN ANNEX  
Annex VI is amended as follows:  
 
(1)  in Part 3, Table 3 is amended as follows:  
(a) The following entries are inserted:  
 
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘014-052-00-7 silanamine, 1,1,1 -
trimethyl -N-
(trimethylsilyl) -, 
hydrolysis products 
with silica; 
pyrogenic, synthetic 
amorphous, nano, 
surface treated silicon 
dioxide  272-697-1 68909 -20-6 Acute Tox. 2  
STOT RE 2  H330  
H373 (lungs) 
(inhalation)  GHS06  
GHS08  
Dgr H330  
H373 (lungs) 
(inhala tion)  EUH066  inhalation:  
ATE = 0,45 
mg/L (dusts or 
mists) ’  
‘035-005-00-7 ammonium bromide  235-183-8 12124 -97-9 Repr. 1B  
Lact.  
STOT SE 3  
STOT RE 1  
Eye Irrit. 2  H360FD  
H362  
H336  
H372 (nervous 
system)  
H319  GHS08  
GHS07  
Dgr H360FD  
H362  
H336  
H372 (nervous 
system)  
H319 ’   
 
‘050-032-00-4 dibutyltin bis(2 -
ethylhexanoate)  220-481-2 2781 -10-4 Muta. 2  
Repr. 1B  H341  
H360FD  GHS08  
Dgr H341  
H360FD      
EN 2  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
STOT RE 1  H372 (immune 
system)  H372 (immune 
system) ’ 
‘050-033-00-X dibutyltin di(acetate)  213-928-8 1067 -33-0 Muta 2  
Repr. 1B  
STOT RE 1  H341  
H360FD  
H372 (immune 
system)  GHS08  
Dgr H341  
H360FD  
H372 (immune 
system) ’    
‘052-001-00-0 tellurium  236-813-4 13494 -80-9 Repr. 1B  
Lact.  
 H360Df  
H362  GHS08  
Dgr H360Df  
H362 ’    
‘052-002-00-6 tellurium dioxide  231-193-1 7446 -07-3 Repr. 1B  
Lact.  
 H360Df  
H362  GHS08  
Dgr H360Df  
H362 ’    
‘056-005-00-3 barium diboron 
tetraoxide  237-222-4 13701 -59-2 Repr. 1B  
Acute Tox. 4  
Acute Tox. 3  H360FD  
H332  
H301  GHS08  
GHS06  
Dgr H360FD  
H332  
H301   inhalation:  
ATE = 1.5 mg/L 
(dusts or mists)  
oral: 
ATE  = 100 
mg/kg bw ’  
‘601-097-00-8 Propylbenzene  203-132-9  103-65-1  Flam. Liq. 3  
Asp. Tox. 1  
STOT SE 3  H226  
H304  
H335  GHS02  
GHS08  
GHS07  
GHS09  H226  
H304  
H335      
EN 3  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
Aquatic Chronic 2  H411  Dgr H411 ’ 
‘603-243-00-6 2,2-dimethylpropan -
1-ol, tribromo 
derivative; 3-bromo -
2,2-
bis(bromomethyl)pro
pan-1-ol 253-057-0 36483 -57-5; 
1522 -92-5 Carc. 1B  
Muta. 2  
 H350  
H341  
 GHS08  
Dgr H350  
H341 ’ 
    
‘604-096-00-0 piperonyl butoxide 
(ISO); 2 -(2-
butoxyethoxy)ethyl 
6-propylpiperonyl 
ether  200-076-7 51-03-6 STOT SE 3  
Eye Irrit. 2  
Aquatic Acute 1  
Aquatic Chronic 1  
 H335  
H319  
H400  
H410  GHS07  
GHS09  
Wng  H335  
H319  
H410  EUH066  M=1  
M=1 ’  
‘604-097-00-6 2,4,6 -tri-tert-
butylphenol  211-989-5 732-26-3 Repr. 1B  
Acute Tox. 4  
STOT RE 2  
Skin Sens. 1B  H360D  
H302  
H373 (liver)  
H317  GHS08  
GHS07  
Dgr H360D  
H302  
H373 (liver)  
H317   oral: 
ATE = 500 
mg/kg bw ’ 
 
‘604-098-00-1 4,4’-
sulphonyldiphenol; 
bisphenol S  201-250-5 80-09-1 Repr. 1B  H360FD  GHS08  
Dgr H360FD ’   
 
‘606-153-00-5 benzophenone  204-337-6 119-61-9 Carc. 1B  H350  GHS08  
Dgr H350 ’   
  
EN 4  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
 
‘606-154-00-0 quinoclamine (ISO); 
2-amino -3-chloro -
1,4-naphthoquinone  220-529-2 2797 -51-5 Carc. 2  
Repr. 2  
Acute Tox. 4  
STOT RE 2  
Eye Irrit. 2  
Skin Sens. 1A  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H361d  
H302  
H373 (blood 
system, 
kidneys)  
H319  
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Wng  H351  
H361d  
H302  
H373 (blood 
system, 
kidneys)  
H319  
H317  
H410   oral: 
ATE = 500 
mg/kg bw  
 
 
 
M=10  
M=10 ’  
‘607-756-00-6 exo-1,7,7 -
trimethylbicyclo[2.2.
1]hept -2-yl acrylate; 
isobornyl acrylate  227-561-6 5888 -33-5 Skin Sens. 1A  H317  GHS07  
Wng  H317 ’    
‘607-757-00-1 daminozide (ISO); 4 -
(2,2-
dimethylhydrazino) -
4-oxobutanoic acid; 
N-
dimethylaminosuccin
amic acid  216-485-9 1596 -84-5 Carc. 2  H351  GHS08  
Wng  H351’     
‘607-758-00-7 4,4'-
oxydi(benzenesulpho201-286-1 80-51-3 Self-react. D  
Aquatic Acute 1  H242  
H400  GHS02  
GHS09  H242  
H410    
M=1    
EN 5  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
nohydrazide)  Aquatic Chronic 1  H410  Dgr M=1’  
‘607-759-00-2 toluene -4-
sulphonohydrazide  216-407-3 1576 -35-8 Self-react. D  H242  GHS02  
Dgr H242 ’    
‘607-760-00-8 2-[N-ethyl -4-[(5-
nitrothiazol -2-
yl)azo] -m-
toluidino]ethyl 
acetate; C.I. Disperse 
Blue 124  239-203-6 15141 -18-1 Skin Sens. 1A  H317  GHS07  
Wng  H317   Skin Sens. 1A; 
H317: C ≥ 
0,001% ’  
‘607-761-00-3 Perfluoroheptanoic 
acid; 
tridecafluoroheptanoi
c acid  206-798-9 375-85-9 Repr. 1B  
STOT RE 1  H360D  
H372 (liver)  GHS08  
Dgr H360D  
H372 (liver) ’    
‘607-762-00-9 methyl N -
(isopropoxycarbonyl)
-L-valyl -(3RS) -3-(4-
chlorophenyl) -β-
alaninate; valifenalate  - 283159 -90-0 Carc. 2  
Aquatic Chronic 2  H351  
H411  GHS08  
GHS09  
Wng  H351  
H411 ’    
‘607-763-00-4 6-[C12 -18-alkyl -
(branched, 
unsaturated) -2,5-
dioxopyrrolidin -1-
yl]hexanoic acid, 
sodium and tris(2 -- - Repr. 1B  
Eye Irrit. 2  H360FD  
H319  GHS08  
GHS07  
Dgr H360FD  
H319 ’     
EN 6  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
hydroxyethyl)ammon
ium salts  
‘607-764-00-X 6-[(C10 -C13) -alkyl -
(branched, 
unsaturated) -2,5-
dioxopyrrolidin -1-
yl]hexanoic acid  - 2156592 -54-
8 Repr. 1B  
Eye Irrit. 2  H360FD  
H319  GHS08  
GHS07  
Dgr H360FD  
H319 ’    
‘607-765-00-5 6-[C12 -18-alkyl -
(branched, 
unsaturated) -2,5-
dioxopyrrolidin -1-
yl]hexanoic acid - - Repr. 1B  H360FD  GHS08  
Dgr H360FD ’    
‘613-341-00-0 clofentezine (ISO); 
3,6-bis(o -
chlorophenyl) -
1,2,4,5 -tetrazine  277-728-2 74115 -24-5 Aquatic Chronic 1  H410  GHS09  
Wng  H410   M=1 ’  
‘613-342-00-6 theophylline; 1,3-
dimethyl -3,7-
dihydro -1H-purine -
2,6-dione  200-385-7 58-55-9 Repr. 1B  H360D  GHS08  
Dgr H360D ’    
‘613-343-00-1 pyridalyl (ISO); 2,6 -
dichloro -4-(3,3-
dichloroallyloxy)phe
nyl 3 -[5-
(trifluoromethyl) -2-- 179101 -81-6 Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H317  
H400  
H410  GHS07  
GHS09  
Wng  H317  
H410    
M=1000  
M=100 ’ 
  
EN 7  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
pyridyloxy]propyl 
ether  
‘613-344-00-7 Pyridine -2-thiol 1 -
oxide, sodium salt; 
pyrithione sodium; 
sodium pyrithione  223-296-5; 
240-062-8 3811 -73-2; 
15922 -78-8 Acute Tox. 3  
Acute Tox. 3  
Acute Tox. 4  
STOT RE 1  
Skin Irrit. 2  
Eye Irrit. 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 2  H331  
H311  
H302  
H372 (nervous 
system)  
H315  
H319  
H317  
H400  
H411  GHS06  
GHS08  
GHS09  
Dgr H331  
H311  
H302  
H372 (nervous 
system)  
H315  
H319  
H317  
H410  EUH070  inhalation:  
ATE = 0.5 mg/L 
(dusts or mists)  
dermal:  
ATE = 790 
mg/kg bw  
oral: 
ATE = 500 
mg/kg bw  
M=100 ’  
‘613-345-00-2 1,3,5 -triazine -2,4,6 -
triamine;  
melamine  203-615-4 108-78-1 Carc. 2  
STOT RE 2  H351  
H373 (urinary 
tract)  GHS08  
Wng  H351  
H373 (urinary 
tract)’    
 
‘615-046-00-2 1,3-bis(1 -isocyanato -
1-
methylethyl)benzene; 
[m-TMXDI]  220-474-4 2778 -42-9 Resp. Sens. 1  
Skin Sens. 1A  H334  
H317  GHS08  
Dgr H334  
H317 ’    
‘615-047-00-8 1,3-
bis(isocyanatomethyl
)benzene; [m -XDI]  222-852-4 3634 -83-1 Resp. Sens. 1  
Skin Sens.  1A H334  
H317  GHS08  
Dgr H334  
H317   Skin Sens. 1A; 
H317: C ≥ 0,001 
%’  
‘615-048-00-3 2,4,6 -triisopropyl -m-
phenylene 218-485-4 2162 -73-4 Resp. Sens. 1  
Skin Sens. 1  H334  
H317  GHS08  
Dgr H334  
H317 ’     
EN 8  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
diisocyanate  
‘615-049-00-9 1,5-naphthylene 
diisocyanate  
[containing < 0.1 % 
(w/w) of particles 
with an aerodynamic 
diameter of below 50 
µm] 221-641-4 3173 -72-6 STOT SE 3  
Skin Irrit. 2  
Eye Irrit. 2  
Resp. Sens. 1  
Skin Sens. 1A  
Aquatic Chronic 3  H335  
H315  
H319  
H334  
H317  
H412  GHS07  
GHS08  
Dgr H335  
H315  
H319  
H334  
H317  
H412 ’    
‘615-050-00-4 1,5-naphthylene 
diisocyanate  
[containing ≥ 0.1 % 
(w/w) of particles 
with an aerodynamic 
diameter of below 50 
µm] 221-641-4 3173 -72-6 Acute Tox. 2  
STOT SE 3  
Skin Irrit. 2  
Eye Irrit. 2  
Resp. Sens. 1  
Skin Sens. 1A  
Aquatic Chronic 3 H330  
H335  
H315  
H319  
H334  
H317  
H412  GHS06  
GHS08  
Dgr H330  
H335  
H315  
H319  
H334  
H317  
H412   inhalation:  
ATE = 0.27 
mg/L (dusts or 
mists) ’  
‘616-237-00-3 fluopicolide (ISO); 
2,6-dichloro -N-[3-
chloro -5-
(trifluoromethyl) -2-
pyridylmethyl]benza
mide  - 239110 -15-7 Repr. 2   H361d  GHS08  
Wng   H361d ‘    
‘616-238-00-9 N-(2-
nitrophenyl)phosphor
ic triamide  477-690-9 874819 -71-3 Repr. 1B  
STOT RE 2  H360Fd  
H373 (kidneys)  GHS08  
Dgr H360Fd  
H373 (kidneys) ’     
EN 9  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘616-239-00-4 
 N-(5-chloro -2-
isopropylbenzyl) -N-
cyclopropyl -3-
(difluoromethyl) -5-
fluoro -1-methyl -1H-
pyrazole -4-
carboxamide; 
isoflucypram  - 1255734 -28-
1 Repr. 2  
Acute Tox. 4  
Skin Sens. 1B  
Aquatic Acute 1  
Aquatic Chronic 1  H361f  
H332  
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Wng  H361f  
H332  
H317  
H410   inhalation:  
ATE = 2.2 mg/L 
(dusts or mists)  
M=10  
M=1 ’ 
 
‘616-240-00-X Reaction mass of 3 -
(difluoromethyl) -1-
methyl -N-
[(1RS,4SR,9RS) -
1,2,3,4 -tetrahydro -9-
isopropyl -1,4-
methanonaphthalen -
5-yl]pyrazole -4-
carboxamide and 3-
(difluoromethyl) -1-
methyl -N-
[(1RS,4SR,9SR) -
1,2,3,4 -tetrahydro -9-
isopropyl -1,4-
methanonaphthalen -
5-yl]pyrazole -4-
carboxamide [>78% 
syn isomers <15% 
anti isomers relative 
content]; isopyrazam  - 881685 -58-1 Carc. 2  
Repr. 1B  
Skin Sens. 1B  
Aquatic Acute 1 
Aquatic Chronic 1  H351  
H360D  
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Dgr H351  
H360D  
H317  
H410   Repr. 1B; 
H360D:  
C ≥ 3%  
 
M = 10  
M = 10 ’ 
  
EN 10  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific Conc. 
Limits, M - Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogra
m, Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. 
Hazard 
statement 
Code(s)  
‘650-058-00-1 Margosa, ext. [from 
the kernels of 
Azadirachta indica 
extracted with water 
and further processed 
with organic 
solvents]  283-644-7 84696 -25-3 Repr. 2  
Skin Sens. 1  
Aquatic Chronic 1  H361d  
H317  
H410  GHS08  
GHS07  
GHS09  
Wng  H361d  
H317  
H410   M = 10 ’ 
 
 
(b) the entries corresponding to index numbers 014-001-00-9; 023 -001-00-8; 601 -024-00-X; 603 -014-00-0; 603 -107-00-6; 604-030-00-0; 
607-111-00-9; 607 -230-00-6; 607 -253-00-1; 607 -254-00-7; 607 -734-00-6; 607 -253-00-1; 607 -254-00-7; 607 -734-00-6; 607 -735-00-1; 
607-736-00-7; 608 -032-00-2; 609 -042-00-X; 613 -012-00-1; 616 -164-00-7 are replaced by the following entries respectiv ely:  
Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
‘014-001-00-9 trichlorosilane  233-042-5 10025 -78-2 Flam. Liq. 1  
Water -react. 1  
Acute Tox. 3  
Acute Tox. 4  
Skin Corr. 1A  
Eye Dam. 1  H224  
H260  
H331  
H302  
H314  
H318  GHS02  
GHS06  
GHS05  
Dgr 
 H224  
H260  
H331  
H302  
H314  EUH014  
EUH029  
EUH071  inhalation:  
ATE = 7,6 
mg/L (vapour)  
oral:  
ATE= 1000 
mg/kg bw ‘   
EN 11  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
  
‘023-001-00-8 divanadium 
pentaoxide; 
vanadium pentoxide  215-239-8 1314 -62-1 Muta. 2  
Carc. 1B  
Repr. 2  
Lact.  
Acute Tox. 3  
Acute Tox. 2  
STOT SE 3  
STOT RE 1  
Aquatic Chronic 2  H341  
H350  
H361fd  
H362  
H301  
H330  
H335  
H372 
(respiratory 
tract, 
inhalation)  
H411  GHS06  
GHS08  
GHS09  
Dgr H341  
H350  
H361fd  
H362  
H301  
H330  
H335  
H372 
(respiratory 
tract, inhalation)  
H411   inhalation:  
ATE = 0,05 
mg/L (dusts or 
mists)  
oral:  
ATE = 220 
mg/kg bw ’  
‘601-024-00-X Cumene  202-704-5 98-82-8 Flam. Liq. 3  
Carc. 1B  
Asp. Tox. 1  
STOT SE 3  
Aquatic Chronic 2  H226  
H350  
H304  
H335  
H411  GHS02  
GHS08  
GHS07  
GHS09  
Dgr H226  
H350  
H304  
H335  
H411 ’    
‘603-014-00-0 2-butoxyethanol; 
ethylene glycol 
monobutyl ether  203-905-0 111-76-2 Acute Tox. 3 
Acute Tox. 4  
Skin Irrit. 2  
Eye Irrit. 2  H331  
H302  
H315  
H319  GHS06  
Dgr H331  
H302  
H315  
H319   inhalation:  
ATE = 3 
mg/L 
(Vapours)  
oral: 
ATE = 1200 
mg/kg bw ’  
‘603-107-00-6 2-(2- 203-906-6 111-77-3  Repr. 1B  H360D  GHS08  H360D   Repr. 1B;   
EN 12  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
methoxyethoxy)etha
nol; diethylene 
glycol monomethyl 
ether  Dgr H360D: C ≥ 3 
%’ 
‘604-030-00-0 4,4’-
isopropylidenediphe
nol; bisphenol A  201-245-8 80-05-7 Repr. 1B  
STOT SE 3  
Eye Dam. 1  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H360F  
H335  
H318  
H317  
H400  
H410  GHS08  
GHS07  
GHS05  
GHS09  
Dgr H360F  
H335  
H318  
H317  
H410   M=1  
M=10 ’ 
 
‘607-111-00-9 2-ethyl -2-[[(1-
oxoallyl)oxy]methyl]
-1,3-propanediyl 
diacrylate; 2,2 -
bis(acryloyloxymeth
yl)butyl acrylate;  
trimethylolpropane 
triacrylate  239-701-3 15625 -89-5 Carc. 2  
Skin Irrit. 2 
Eye Irrit. 2  
Skin Sens. 1  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H315  
H319  
H317  
H400  
H410  GHS08  
GHS07  
GHS09  
Wng  H351  
H315  
H319  
H317  
H410   M=1  
M=1  D’ 
‘607-230-00-6 2-ethylhexanoic acid 
and its salts, with the 
exception of those 
specified elsewhere 
in this Annex  - - Repr. 1B  H360D  GHS08  
Dgr H360D     
‘607-253-00-1 cyfluthrin (ISO); α -
cyano -4-fluoro -3-
phenoxybenzyl -3-
(2,2-dichlorovinyl) -269-855-7 68359 -37-5 Lact.  
Acute Tox. 2  
Acute Tox. 2  H362  
H330  
H300  GHS06  
GHS08  
GHS09  H362  
H330  
H300   inhalation:  
ATE = 0,14 
mg/L (dusts or 
  
EN 13  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
2,2-
dimethylcyclopropan
ecarboxylate  STOT SE 1  
Aquatic Acute 1  
Aquatic Chronic 1  
 H370 (nervous 
system)  
H400  
H410  
 Dgr H370 (nervous 
system)  
H410  
 mists)  
oral: 
ATE = 14 
mg/kg bw  
M = 1000000  
M = 1000000 ’ 
‘607-254-00-7 beta-cyfluthrin 
(ISO); reaction mass 
of rel -(R)-cyano(4 -
fluoro -3-
phenoxyphenyl)meth
yl (1S,3S) -3-(2,2-
dichloroethenyl) -2,2-
dimethylcyclopropan
e-1-carboxylate and 
rel-(R)-cyano(4 -
fluoro -3-
phenoxyphenyl)meth
yl (1S,3R) -3-(2,2-
dichloroethenyl) -2,2-
dimethylcyclo propan
e-1-carboxylate  
 - 1820573 -27-
0 Lact.  
Acute Tox. 2  
Acute Tox. 2  
STOT SE 1  
Aquatic Acute 1  
Aquatic Chronic 1  
 H362  
H330  
H300  
H370 (nervous 
system)  
H400  
H410  
 GHS06  
GHS08  
GHS09  
Dgr H362  
H330  
H300  
H370 (nervous 
system)  
H410  
 
  inhalation:  
ATE = 0,081 
mg/L (dusts or 
mists)  
oral: 
ATE = 11 
mg/kg bw  
M = 1000000  
M = 1000000 ’ 
 
‘607-734-00-6 pentapotassium 
2,2’,2’’,2’’’,2’’’’ -
(ethane -1,2-
diylnitrilo)pentaaceta404-290-3 7216 -95-7 Repr. 1B  
Acute Tox. 4  H360D  
H332  
H373 GHS08  
GHS07  
Dgr H360D  
H332  
H373  Repr. 1B ; 
H360D: C ≥ 3 
% 
  
EN 14  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
te STOT RE 2  
Eye Irrit. 2  (inhalation)  
H319  (inhalation)  
H319  inhalation:  
ATE = 1,5 
mg/L (dusts or 
mists) ’ 
‘607-735-00-1 N-
carboxymethylimino
bis(ethylenenitrilo)te
tra(acetic acid)  200-652-8 67-43-6 Repr. 1B  
Acute Tox. 4  
STOT RE 2  
Eye Irrit. 2  H360D  
H332  
H373 
(inhalation)  
H319  GHS08  
GHS07  
Dgr H360D  
H332  
H373 
(inhalation)  
H319   Repr. 1B ; 
H360D: C ≥ 3 
% 
inhalation:  
ATE = 1,5 
mg/L (dusts or 
mists) ’  
‘607-736-00-7 pentasodium 
(carboxylatomethyl)i
minobis(ethylenenitri
lo)tetraacetate  205-391-3 140-01-2 Repr. 1B  
Acute Tox. 4  
STOT RE 2  
 H360D  
H332  
H373 
(inhalation)  
 GHS08  
GHS07  
Dgr H360D  
H332  
H373  
  Repr. 1B ; 
H360D: C ≥ 3 
% 
inhalation:  
ATE = 1,5 
mg/L (dusts or 
mists) ’  
‘608-032-00-2 acetamiprid (ISO); 
(1E)-N-[(6-
chloropyridin -3-
yl)methyl] -N'-cyano -
N-
methylethanimidami
de; (E) -N1-[(6-
chloro -3-- 135410 -20-7 
160430 -64-8 Repr. 2  
Acute Tox. 3  
Aquatic Chronic 1  
Aquatic Acute 1  H361d  
H301  
H410  
H400  
 GHS08  
GHS06  
GHS09  
Dgr H361d  
H301  
H410   oral: 
ATE = 140 
mg/kg bw  
M = 10  
M = 10 ’ 
  
EN 15  EN Index No  Chemical Name  EC No  CAS No  Classification  Labelling  Specific 
Conc. Limits, 
M- Notes  
Hazard Class 
and Category 
Code(s)  Hazard 
statement 
Code(s)  Pictogram, 
Signal 
Word 
Code(s)  Hazard 
statement 
Code(s)  Suppl. Hazard 
statement 
Code(s)  
pyridyl)methyl] -N2-
cyano -N1-
methylacetamidine  
‘609-042-00-X pendimethalin (ISO); 
N-(1-ethylpropyl) -
2,6-dinitro -3,4-
xylidene  254-938-2 40487 -42-1 Repr. 2  
Aquatic Acute 1  
Aquatic Chronic 1  H361d  
H400  
H410  GHS08  
GSH09  
Wng  H361d  
H410    
M=100  
M=10 ’  
‘613-012-00-1 bentazone (ISO); 3 -
isopropyl -2,1,3 -
benzothiadiazine -4-
one-2,2-dioxide  246-585-8 25057 -89-0 Repr. 2  
Acute Tox. 4  
Eye Irrit. 2  
Skin Sens. 1  H361d  
H302  
H319  
H317  GHS08  
GHS07  
Wng  H361d  
H302  
H319  
H317   oral: ATE = 
1600 mg/kg 
bw’ 
 
‘616-164-00-7 dimoxystrobin (ISO); 
(2E)-2-{2-[(2,5 -
dimethylphenoxy)me
thyl]phenyl} -2-
(methoxyimino) -N-
methylacetamide; 
(E)-2-
(methoxyimino) -N-
methyl -2-[α-(2,5-
xylyloxy) -o-
tolyl]acetamide   149961 -52-4 Carc. 2  
Repr. 2  
Acute Tox. 4  
Aquatic Acute 1  
Aquatic Chronic 1  H351  
H361d  
H332  
H400  
H410  GHS08  
GHS07  
GHS09  
Wng  H351  
H361d  
H332  
H410   inhalation:  
ATE = 1.3 
mg/L (dusts or 
mists)  
M=100  
M=100 ’ 
 
(c) the entr y corresponding to index number 615-007-00-X is deleted.